Mani Subramanian is the founder of OrsoBio. OrsoBio has raised $127M in total funding. Latest round: Series B. Based in Palo Alto, CA.
Mani Subramanian, MD, PhD, is the Founder and CEO of OrsoBio, a clinical-stage biopharmaceutical company focused on developing novel therapies for severe metabolic disorders such as obesity, type 2 diabetes, and nonalcoholic steatohepatitis. He co-founded OrsoBio in 2021, bringing extensive experience in metabolic disease therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library